Investigating a signature of temozolomide resistance in GBM cell lines using metabolomics

From National Research Council Canada

DOIResolve DOI:
AuthorSearch for: ; Search for: ; Search for: 1; Search for: ; Search for:
  1. National Research Council of Canada. Information and Communication Technologies
FormatText, Article
Subjectaconitic acid; adenosine; alanine; arginine; choline; citric acid; creatine; glucose; glutamic acid; glutamine; glutathione; glycerophosphate; histidine; inositol; isocitric acid; isoleucine; leucine; lomeguatrib; methionine; methylated DNA protein cysteine methyltransferase; phosphorylcholine; proline; serine; succinic acid; taurine; temozolomide; threonine; tryptophan; unindexed drug; valine; amino acid metabolism; antineoplastic activity; cancer cell line; cancer resistance; cell viability; citric acid cycle; concentration response; cytotoxicity; down regulation; drug sensitivity; enzyme inhibition; genetic transcription; glioblastoma; glioblastoma multiforme cell line; glycolysis; human cell; human tissue; metabolite; metabolomics; primary tumor; upregulation
Publication date
Peer reviewedYes
NPARC number21276985
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifierf46dfba2-3983-4ffd-8307-a73e2c6cb594
Record created2015-11-10
Record modified2020-04-22
Date modified: